Evaluation of Preoperative Oral Rehydration Solution in Colectomy
NCT ID: NCT02062788
Last Updated: 2017-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
10 participants
INTERVENTIONAL
2014-02-28
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Preoperative Oral Carbohydrates on Quality of Recovery in Laparoscopic Colorectal Surgery Patients
NCT02537262
Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery
NCT00868400
A Trial of Preoperative CHO Drinks on Postoperative Walking Capacity in Colorectal Surgery
NCT01844375
The Effect of Oral Carbohydrate Administration on Postoperative Well-being
NCT05402592
Effect of Preoperative Oral Carbohydrates on the Insulin Resistance of Elderly Patients
NCT04206189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. The change in HOMA-IR with shorter preoperative Nothing by mouth (NPO) period in ERAS patients
1. HOMA-IR Index equation (evaluation of Insulin resistance)
= Insulin (μU/ml) X blood glucose (mg/dl) / 405
2. HOMA-IR was statistically proven to have been lowered in patients who received ORS 2hr prior to surgery.
3. Reference
* Increased insulin resistance induces hyperglycemia
* Toxicity of post-op hyperglycemia and their relation to post-op complications
* Insulin resistance increases in procedures such as herniorrhaphy or laparoscopic cholecystectomy. Administration of preoperative carbohydrates decrease post-op nausea and vomiting
* Conventional pre-op 8hr fasting increases insulin resistance and influences increased glucose levels
3. Additional benefits of shorter preoperative fasting
1. Relieve of stress of fasting
2. Help stabilize post-op triglyceride, cortisol, and glucose levels
3. Reduce infectious complications
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ORS group
Oral rehydration solution (ORS) treated group
Oral rehydration solution
Preoperative day #1: able to drink Oral rehydration solution (ORS) freely On day of Surgery: Allowed administration until 2hrs prior to surgery. 8AM patients(the first patients to undergo surgery of the day) are recommended to administer ORS at 5:30AM
Non-ORS group
Oral rehydration solution (ORS) untreated group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral rehydration solution
Preoperative day #1: able to drink Oral rehydration solution (ORS) freely On day of Surgery: Allowed administration until 2hrs prior to surgery. 8AM patients(the first patients to undergo surgery of the day) are recommended to administer ORS at 5:30AM
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: adults age 19\~75
* Patients undergoing elective colon cancer surgery
* Able to take the ORS per orally. Able to swallow without trouble of aspiration tendencies
* BMI of less than 27.5
* Child-Turcotte-Pugh Classification score of less than 6
Exclusion Criteria
* food allergy
* abdominal distension at present
* prior gastric surgery
19 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sung-Bum Kang
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sung-Bum Kang, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-1310/224-007
Identifier Type: OTHER
Identifier Source: secondary_id
ORS-colectomy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.